天士力(600535.SH):擬14.89億元出售天士營銷99.9448%股權
格隆匯6月12日丨天士力(600535.SH)公佈,為滿足公司戰略發展需要,增強公司可持續發展能力和核心競爭力,公司結合自身特點,擬通過出售公司醫藥商業經營模式下的分銷配送業務板塊資產,集中優勢資源聚焦醫藥工業,繼續推進現代中藥、生物藥和化學藥的協同發展,構築創新醫藥研發集羣。
此次交易公司及其間接控制的天津善祺、天津致臻、天津瑞展、天津瑞臻、天津瑾祥和天津晟隆等6家合夥企業1擬向重慶醫藥出售天士營銷99.9448%股權:其中,公司擬向重慶醫藥出售天士營銷88.4937%股權,公司間接控制的6家合夥企業擬向重慶醫藥出售其合計持有的天士營銷11.4511%股權,重慶醫藥以支付現金的方式進行購買,交易對價以評估值為基礎由交易雙方協商確定。截至評估基準日,天士營銷100%股權的評估值約14.13億元,雙方協商確定天士營銷99.9448%股權交易價格約14.89億元。
根據華康評估出具的《資產評估報告》,以2019年12月31日為評估基準日,採用資產基礎法和市場法進行評估並最終選取資產基礎法作為評估結果。此次交易擬出售標的公司100%股權的評估值約14.13億元,評估增值約3.03億元,評估增值率為27.30%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.